Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 5 FDA-Approved Drugs That Disappointed Investors in 2013
5 FDA-Approved Drugs That Disappointed Investors in 2013
5 FDA-Approved Drugs That Disappointed Investors in 2013
Submitted by
admin
on November 13, 2013 - 10:33pm
Source:
Motley Fool
News Tags:
FDA
Amarin
Vivus
Dendreon
Arena Pharmaceuticals
Provenge
Vascepa
Iclusig
Ariad Pharmaceuticals
Belviq
Qsymia
Headline:
5 FDA-Approved Drugs That Disappointed Investors in 2013
Do Not Allow Advertisers to Use My Personal information
